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Abstract
Low back pain (LBP) is a common health problem among adults of working age population, and its prevalence or incidence 
increases with increasing in age. The purpose of this review was to examine the real-world prevalence or incidence of LBP. 
A systematic review of the literature was conducted in accordance to the PRISMA guideline. Allied and Complementary 
Medicine Database, Cumulative Index of Nursing and Allied Health Literature, MEDLINE, SportDiscuss and Scopus elec-
tronic databases were searched using specifically developed search strategies to identify studies using patients’ electronic 
medical records published in English up to February 2019. The quality of the included studies was assessed using a tool 
that consists of ten items addressing a risk of bias. The search yielded 756 published studies, of which 13 were deemed 
relevant and were included in this review. The included studies reported incidence or prevalence data from Canada, United 
States of America (USA), Sweden, Belgium, Finland, Israel, and Netherlands. All the included studies were assessed to be 
methodologically sound (low risk of bias). The prevalence and incidence of LBP ranged from 1.4 to 20.0% and 0.024–7.0%, 
respectively. Three studies reported that the Odds of LBP in male patient was higher than their female counterparts (odds 
ratio > 1; range 1.11–17.29). Nine studies identified the risk factors of LBP to be age, sex, and race. The remaining four 
studies also listed high intensity of physical activity, high spinal load, lifting, bending, and twisting as the risk factors for 
LBP. The results of this study highlighted there is a substantial difference within studies that estimated the prevalence and 
incidence of LBP. This finding could inform healthcare policy makers to critically examine the data sources of prevalence 
and incidence studies; this in return might help for resource allocation to manage the condition.
PROSPERO registration number: CRD42017078598, https ://www.crd.york.ac.uk/prosp ero/.
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Introduction
Low back pain is one of the common health problems that 
50–80% of adults experience at some point in their life [1, 
2]. It is believed that adults of working age are the most vul-
nerable group of LBP, which is ranked as the highest cause 
of disability than any other condition globally [3, 4]. The 
overall burden of LBP arising from ergonomic exposures at 
work was estimated at 21.8 million [95% Confidence Inter-
val (CI) 14.5–30.5] disability adjusted life years (DALYs) 
in 2010 [3]. Of this, 8.3 M DALYs were in females and the 
remaining 13.5 million were in males.
Despite several peer-reviewed published studies on the 
prevalence or incidence of LBP, there is little consensus 
regarding its epidemiology and its risk factors [5–8]. For 
example, Hoy et al. [8] reported a point prevalence estimate 
of LBP that ranged from 1.0 to 58.0%. A review of 56 stud-
ies from Walker has also indicated that the point prevalence 
of LBP was between 12.0 and 33.0% [7]. Moreover, 1-year 
and lifetime prevalence of LBP that ranged between 0.8% and 
82.5% and 11.0–84.0%, respectively, was reported from stud-
ies carried out worldwide including low-income countries [7, 
8]. The prevalence of LBP in high-income countries was esti-
mated at 30.0%, which is higher than low-income countries, 
18.0% [7]. The 1-year incidence of people who have any epi-
sode and first ever episode of LBP ranged from 1.5 to 36.0%, 
and 6.3–15.4%, respectively [7]. Further, it has been suggested 
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that the prevalence or incidence of LBP is increasing with 
age [9, 10]. A nationwide study in Finland reported that the 
prevalence of LBP for 7-year-olds, 10-year-olds and 14- to 
16-year-olds was 1.0%, 6.0%, and 18.0%, respectively [9].
With regard to the potential risk factors of LBP, many 
personal and environmental factors have been identified [6, 
11, 12]. Personal factors such as metabolism, biochemistry, 
physical factors (a long back), and depressive tendencies 
were identified as a risk factors of LBP [6], whereas job 
satisfaction, working with heavy weights, lengthy period of 
standing, forward bending, and carrying school backpacks 
were identified as environmental risk factors of LBP [11]. 
A recent study on gender–age environmental associates of 
adolescent LBP have also found that girls were likely to 
report LBP than boys [13].
The previous published reviews of prevalence and inci-
dence of LBP studies were focused on evaluating peer-
reviewed journals conducted via population-based longitu-
dinal and cross-sectional designs. One of the limitations of 
the longitudinal and cross-sectional study designs is lack 
of generalisability to the real-world settings [14]. Some of 
the reasons for their lack of generalisability include inap-
propriate subject selection criteria, inadequate randomisa-
tion, and insufficient sample size. Studies conducted using 
real-world data or routinely collected data from a variety of 
sources such as electronic health records, claims and billing 
activities, claims and billing data, and disease registries are 
believed to solve the problem of generalisability [15]. To the 
best of our knowledge, there is no systematic review that has 
reported incidence and prevalence of LBP in the real-world. 
The purpose of this review was, therefore, to systematically 
evaluate incidence and prevalence of LBP in the real-world. 
Understanding the prevalence and incidence of LBP from 
studies conducted using patients’ electronic medical records 
may help put appropriate public health intervention in place 
to alleviate the burden associated with the condition.
Methods
This systematic review has been conducted in accordance 
with the Preferred Reporting Items for Systematic Reviews 
and Meta-Analysis (PRISMA) guideline and the recom-
mendations listed by Gasparyan and colleagues [16, 17]. 
The review was registered with PROSPERO—the Interna-
tional Prospective Register of Systematic Reviews CRD: 
42017078598.
Search strategy
A search of literature published on Allied and Comple-
mentary Medicine Database (AMED), Cumulative Index 
of Nursing and Allied Health Literature (CINAHL), 
MEDLINE, SportDiscuss, and Scopus electronic databases 
were performed up to February 2019. The search terms used 
were back pain, chronic low back pain, chronic musculo-
skeletal pain, rheumatic low back pain, low back pain, real 
world, musculoskeletal disorder, incidence, prevalence, and 
epidemiology. These search terms were combined using con-
junctions such as ‘AND’ and ‘OR’. Inclusion criteria were: 
retrospective observational database studies investigating the 
prevalence and incidence of low back pain in adult popula-
tion, conducted in any geographical location and published 
on any date, studies carried out using largescale database, 
and studies published in English language. Exclusion cri-
teria: abstract unavailable, studies not yet fully completed, 
systematic reviews, narrative literature reviews, conference 
papers, cross sectional studies, surveys, and studies not pub-
lished in English. Two independent researchers FF and TG 
were involved in the search and screening of the articles. 
Full-text articles were obtained and studies were excluded 
if they did not meet the inclusion criteria. Any disagreement 
in the study selection was resolved through discussion with 
a third reviewer IO where it was important. Studies utilising 
data from retrospective patient electronic medical records 
were included.
Risk of bias assessment
The included studies were assessed for quality using a risk of 
bias tool recommended by Hoy et al. [5]. This tool evaluates 
studies for measurement bias, selection and analysis bias, 
and contains ten items. The overall assessment of risk of 
bias was rated as low, moderate, and high risk of bias. Those 
studies, which were rated as high risk of bias (below 75%), 
were excluded from the review.
Data extraction and analysis
Data extraction was made from the included studies. The 
following information were extracted: country, year of publi-
cation, citation, database, population type, sample size, case 
definition, age, sex, prevalence, and incidence. A descriptive 
analysis of the extracted results was performed. No meta-
analysis was undertaken due to the heterogeneity of meth-
odologies used across the included studies.
Results
Search results
The electronic database search yielded 756 published stud-
ies. After the removal of duplicates, 397 records remained 
for screening. Irrelevant titles (n = 262) were excluded, leav-
ing (n = 135) for further examination by abstracts. After 
621Rheumatology International (2019) 39:619–626 
1 3
reading the abstracts, 27 potential studies were found eligi-
ble and their full-texts were printed. Finally, only 13 articles 
were included for data synthesis (Fig. 1).
Description of the studies
Various sources of data were reported in the included stud-
ies including the National Dutch Register [18]; Regie de’l 
Assurance Maladie du Quebec [19]; Skane Health Care Reg-
ister [20]; Truven Health Market Scan Commercial Claims 
and Encounters [21]; National Hospital Discharge Register 
of Finland [22]; registration Network Groningen [23], US 
Defence Medical Epidemiology Database [24], the Intego 
Database [25], and the Emergency Department Information 
System [26] (Table 1). The included studies were conducted 
in Belgium [25], Canada [19, 26], Finland [22], the Nether-
lands [18, 22, 27], Sweden [20], USA [21, 24, 28, 29], and 
Israel [30]. The sample size used to estimate the prevalence 
and incidence of LBP in the included studies ranged from 
3900 to 7.5 million. The types of population included in the 
studies were industry workers (aerospace, defence industry, 
technology space and telecommunication), military person-
nel, self-reported patients, and adults living in USA, Quebec, 
and Sweden. All included studies scored ≥ 80% of risk of 
bias (low risk) for quality.
Prevalence
Five studies reported the prevalence rates of LBP 
(Table 2). The mean prevalence of LBP reported from 
the studies ranged from 1.4 to 15.6% [18, 20, 21, 24, 26]. 
The highest prevalence rates of LBP [19] were reported 
from workers in the aerospace and defence industry in the 
Unites States Benchmark Companies, whereas the lowest 
prevalence rates were reported from the residents of Que-
bec, Canada [19]. The substantial differences within the 
two studies may explain that working in industry could be 
one of the major risk factors of LBP [19, 21]. Two studies 
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Fig. 1  Flow diagram demonstrating the study selection and inclusion process
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have also reported that the prevalence rates of LBP in 
females were higher than males, which is contrary to the 
existing knowledge of LBP burden [20, 21].
Incidence
The incidence rate of LBP was reported in ten studies 
[18, 21–25, 27–30]. The overall mean incidence of LBP 
reported from the nine studies ranged between 0.024 
and 7.0%. The highest and lowest incidence of LBP was 
reported in the USA and the Netherlands, respectively [21, 
27]. One of the explanatory factor for the difference in the 
incidence rate estimate may be the type of population con-
sidered in the studies. For example, people working in the 
aerospace and defence industry in USA were highly vul-
nerable than those working in the healthcare, mining and 
quarrying sector in the Netherland. Two studies reported 
that the incidence of LBP in female was higher than in 
male [21, 25]. Despite the difference in geographical loca-
tions where the studies were conducted, the incidence rates 
some studies have reported were approximately the same 
[22–24, 28] (Table 3).
Table 1  Summary of the characteristics of the studies reporting prevalence/incidence of LBP
References Country (database) Population type Sample size Age (years) Risk of 
bias score 
(%)
Beaudet et al. [19] Canada (Regie de’l Assur-
ance Maladie du Quebec)
All adults of Quebec 401,264
M = 49%; F = 51%
≥ 18 Low risk
Goetzel et al. [21] USA (Truven Health Market 
Scan Commercial Claims 
and Encounters Database)
Industry workers 1.1–1.2 million
M = 70%, F = 30%
44.6 Low risk
Joud et al. [20] Sweden (Skane Health Care 
Register)
All inhabitants of Skane 
population
938,397
M = 43%, F = 57%
≥ 20 Low risk
Mattila et al. [22] Finland (National Hospital 
Discharge Register of 
Finland)
Young male conscripts 387,070 ≥ 19 Low risk
Spijker-Huiges et al. [23] Netherlands (Registration 
Network Groningen)
First episode of radiating 
LBP
3900
M = 49%, F = 51%
≥ 18 Low risk
Ernat et al. [28] USA (US Defense Medical 
Epidemiology Database)
Military personnel 26,044 cases ≥ 18 Low risk
Knox et al. [24] USA (US Defence Medical 
Epidemiology Database)
Military personnel 557,059 cases (13,754,261 
person years)
≥ 18
Bartholomeeusen et al. [25] Belgium (Intego Database) Self-reported patients 74,863
M = 49.4%, F = 50.6%
≥ 18 Low risk
Kuijer et al. [18] Netherlands (National 
Dutch Register)
Workers 7.5 million
M = 48%, F = 52%
≥ 18 Low risk
Miedema et al. [27] Netherlands (Netherlands 
Centre for Occupational 
Diseases Registries)
Workers 512,918 ≥ 18 Low risk
Waterman et al. [29] USA (Consumer Product 
Safety Commission’s 
National Electronic Injury 
Surveillance System)
All inhabitants 2,067,081 cases (1.48 bil-
lion person year)
≥ 24 Low risk
Moshe et al. [30] Israel (Israel National 
Defence)
Army recruits 159,295 ≥ 18 Low risk
Edwards et al. [26] Canada (Emergency Depart-
ment Information System)
All patients of Halifax, 
Canada
406,918 ≥ 18 Low risk
Table 2  Summary of the characteristics of the studies reporting prev-
alence of LBP
M male, F female
References Prevalence
Beaudet et al. [19] 1.4% (M = 1.6%, F = 1.5%)
Goetzel et al. [21] 15.6% (M = 14.7%, F = 17.8%)
Joud et al. [20] 3.0% (M = 1.0%, F = 2.0%)
Spijker-Huiges et al. [23] 1.7%
Edwards et al. 2018 [26] 3.2%
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LBP definition
There was virtually no agreement among researchers 
regarding the definition of LBP (Table 4). Some of the 
definitions of LBP included are 3digits ICD-9 and ICD-10 
codes, lumbar and other intervertebral disc disorder with 
radiculopathy, LBP (M54.5), and dorsalgia (M54.5). The 
study by Bartholomeeusen et al. [25] and Spijker-Huiges 
et al. [23] also reported LBP symptom/complaint (LO3), 
back syndrome without radiating pain (L84), and back 
syndrome with radiating pain (L86) for LBP definition. 
The Dutch Classification for Occupational Health Care 
and Social Affairs has also defined a nonspecific LBP as 
acute (L101, M545), subacute (L102, M545) and chronic 
(L103, M545).Overall, various kinds of LBP are used in 
the included studies. The use of various kinds of LBP defi-
nition may lead to the wrong of use of LBP treatment.
Gender as a risk factor of LBP
As it is shown in Table 5, six studies reported data that could 
be used to investigate the potential risk factor of LBP using 
odds ratios. The odds ratios were calculated by dividing the 
odds of male by the odds of female in the selected studies. 
If the odds ratio is greater than one, then being male is con-
sidered to be associated with having LBP since being male 
increases the odds of LBP. Of those six studies, three studies 
reported that being male was associated with having LBP 
higher than female [18, 19, 23].
Discussion
The aim of this systematic literature review was to report 
LBP prevalence and incidence estimate from studies using 
patient electronic medical records. The included studies 
Table 3  Summary of the characteristics of the studies reporting incidence of LBP
M male, F female
References Incidence
Goetzel et al. [21] 7.0% M = 6.7%, F = 8.0%
Mattila et al. [22] 2.0% M = 1.3%, F = 0.7%
Spijker-Huiges et al. [23] 1.0%
Ernat et al. [28] 3.0%
Knox et al. [24] 4.0%
Bartholomeeusen et al. [25] 5.1% (95% CI 4.9%, 5.3%), F = 5.3% (95% CI 5.1%, 5.5%), M = 4.9% (95% CI 4.7%, 5.2%)
Kuijer et al. [18] 5.4%; M = 5.0%, F = 4.0%
Miedema et al. [27] 0.024% (95% CI 0.022–0.027%), M = 0.031% (95% CI 0.028%, 0.035%), F = 0.003 (95% 
CI 0.002%, 0.005%)
Waterman et al. [29] 0.14%
Moshe et al. 2016 [30] 0.05%
Table 4  LBP definition of the studies
ICD international classification of disease, ICPC international classification of primary care
References LBP definition
Beaudet et al. [19] 3-digits ICD-9 codes 721, 722, 724 or 739
Joud et al. [20] ICD-10: Lumbago with sciatica (M54.4), LBP (M54.5), other dorsaliga unspecified (M54.9)
Mattila et al. [22] ICD-10 (M51.1-lumbar and other intervertebral disc disorder with radiculopathy), M54.5-LBP and M54.9-dorsalgia. 
ICD-9 by codes 7227C, 3539X, 7242A, 7245A, and 7249X
Spijker-Huiges et al. [23] L02 and L03 for having pre-history and post-history of LBP in the DUTCH version of the ICPC-1
Ernat et al. [28] ICD-9CM code 724.20
Knox et al. [24] ICD-9CM code 724.20
Bartholomeeusenetal [25] LO3 (Low back symptom), L84 (back syndrome without radiating pain) or L86 (Back syndrome with radiating pain)
Kuijer et al. [18] Acute (L101, M545), subacute (L102, M545) and chronic (L103, M545)
Moshe et al. 2016 [30] Criteria based on the Israeli Defence Force book of medical records
Edwards et al. 2018 [26] ICD codes: LBP with no potential nerve root involvement; LBP with potential nerve root involvement; and LBP 
with attributed to trauma or other secondary factors
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reported incidence or prevalence data from North Amer-
ica and Europe including USA, the Netherlands, Canada, 
Sweden, Finland, Belgium and Israel. The methodologi-
cal approach used as a search strategy identified no studies 
from developing countries. This may be due to the lack of 
proper and incomplete record keeping or registries in these 
countries.
It is well understood that the methodological quality of 
studies are different from one another. For this reason, the 
included studies were assessed for quality against the check-
list criteria of Hoy et al. [31]. Overall, the included studies 
were assessed as low risk of bias (≥ 80%). Assessment of the 
included studies for quality was important to have a reason-
able trust on the findings of the review. It was also helpful 
to make comparison between studies. The sample size con-
sidered to estimate the prevalence or incidence of LBP in 
the included studies ranged from about 3900 to 7.5 million.
The findings of our review indicated that the mean preva-
lence and incidence of LBP ranged from 1.4 to 20.0% and 
0.024–7.0%, respectively. An annual prevalence of LBP 
ranged from 22.0 to 65.0% [7], and 8.0–82.0% [8] which is 
approximately four times higher than the current review was 
reported. Parallel to this, previous systematic review on the 
incidence LBP ranged from 24.0 to 80.0% [8]. Our results 
are lower than those of prospective studies on prevalence 
(6.0–25.0%) and incidence (20.0–28.0%) of LBP [32, 33]. 
One possible reasons for the discrepancy in the prevalence 
or incidence estimate within the reviewed studies could be 
the type of population and the methodology considered in 
each study.
Our findings of the prevalence and risk factors of LBP 
were also compared to those of reviews conducted in Africa 
[2, 34]. The mean annual LBP prevalence among adults in 
Africa was 50.0% [34]. We observed that the prevalence of 
LBP was approximately four times higher in Africa popu-
lation compared to the prevalence of LBP reported in the 
current review. On the other hand, a contradiction were 
observed between Louw et al. [34] and Volinn [2] where 
the latter reported higher prevalence of LBP in high-income 
countries than low-middle income countries. Similarly, the 
main reason for the inconsistencies in the findings of LBP 
prevalence may be due to the study design, patient age, par-
ticipants, and the mode of data collection adopted within 
the studies included in this review. The impact of reporting 
inconsistence prevalence or incidence of LBP within studies 
may have resulted in inefficient resource allocation. Thus, 
we suggest that using prevalence and incidence estimate 
from studies utilising real-world evidence is important for 
decision-making. With regard to risk factors of LBP, we 
observed a new insight within the current review. In the pre-
vious reviews, the risk factors of LBP were associated with 
psychological distress, depressive mood, and somatization 
[11], whereas in the present review it was suggested that sex 
might be a risk factor of LBP.
Similar to other systematic reviews, this review has some 
strengths and limitations. The strength of this review lies 
with the process of review it has conducted. Three independ-
ent reviewers were involved in the review process, whereas 
two of them have participated in the identification and analy-
sis. The other strength of our review lies in the prevalence 
and incidence estimate reported; the samples’ size of the 
included studies in the current review was based on a large 
sample, which enhances the generalisability of the findings. 
This review may have a selection bias due to the exclusion 
of studies with paediatric patients. Some of the included 
studies have also used information from a heterogeneous 
cohort and may not represent a routinely collected data. Fur-
ther, it has been difficult to find literatures from developing 
countries; this was due to the lack of proper and incomplete 
record keeping or registries.
Based on the real-world evidence our findings suggest 
that LBP is a global burden to the individual, health system 
and society. In addition to other predictors or risk factors of 
LBP such as depression and psychological distress, being 
male or female may also be one that requires attention from 
clinicians and patients themselves. The results of this review 
could be used to inform healthcare authorities to evaluate 
alternative treatment options to prevent the incidence and 
reduce the prevalence of LBP. Further real-world studies 
are required to determine the effectiveness of such treatment 
options.
Conclusion
This systematic review highlighted there is a substantial 
difference within studies that estimated the prevalence and 
incidence of LBP. The prevalence and incidence estimate 
of LBP based on routinely collected data ranged from 1.4 
to 20.0% and 0.024–7.0%, respectively. The findings of this 
study have also indicated that sex might be a risk factor for 
LBP. We believe that our findings on real-world prevalence 
and incidence of LBP may help public health practitioners 
Table 5  The odds of gender (male and female) for LBP
References Odds ratio
Beaudet et al. [19] 1.11
Goetzel et al. [21] 0.34
Joud et al. [20] 1.00
Spijker-Huiges et al. [23] 1.32
Bartholomeeusen et al. [25] 0.05
Moshe et al. 2016 [30] 1.47
Kuijer et al. [18] 17.29
Edwards et al. 2018 [26] 0.89
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and healthcare policy makers to evaluate alternative treat-
ment options to prevent the incidence and reduce the preva-
lence of LBP. Further research studies are required to esti-
mate the prevalence and incidence and identify the risk 
factors for LBP, particularly in developing countries using 
patients of electronic medical records.
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